Pages that link to "Q36561610"

The following pages link to Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model (Q36561610):

Displaying 9 items.

• Tailored design of NKT-stimulatory glycolipids for polarization of immune responses (Q39196835) (← links)
• Targeting iNOS to increase efficacy of immunotherapies (Q43024830) (← links)
• Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner. (Q48166062) (← links)
• Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment. (Q48183968) (← links)
• SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells (Q51069953) (← links)
• Biological Roles of Aberrantly Expressed Glycosphingolipids and Related Enzymes in Human Cancer Development and Progression. (Q54943815) (← links)
• Vaccination with human papillomavirus-18 E1 protein plus α-galactosyl-ceramide induces CD8 cytotoxic response and impairs the growth of E1-expressing tumors (Q91295805) (← links)
• Immunomodulatory roles of nitric oxide in cancer: tumor microenvironment says "NO" to antitumor immune response (Q92890513) (← links)
• α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials (Q93062542) (← links)